Artrit Stem Cell Therapy Success Rate — Clinical Evidence & Patient Outcomes
65–80%
of patients report meaningful improvement
Based on published clinical trial data
What Does "65–80% Success Rate" Mean?
In published clinical studies, 65–80% of patients treated with mesenchymal stem cell (MSC) therapy for romatoid artrit & enflamatuvar artrit experienced statistically significant and clinically meaningful improvements. "Meaningful improvement" is measured using validated clinical scales specific to each condition — not just subjective reports.
It's important to note that success rates vary based on disease severity, patient age, overall health, and treatment protocol. Our clinical team evaluates each patient individually to provide realistic expectations during the consultation phase.
What Improvement Looks Like — Timeline
Expected Improvement Timeline
2–4 hafta içinde eklem iltihabında ve ağrıda azalma. 1–3 ayda kavrama gücünde ve hareketliliğinde iyileşme. 3–6 ayda ilaç bağımlılığında azalma. Birçok hastada 6–12 ayda kalıcı remisyon.
Factors That Influence Success
Disease Stage
Earlier-stage conditions generally respond better to stem cell therapy. Patients with mild-to-moderate disease typically achieve the best outcomes. Advanced cases may still benefit but with more variable results.
Disease Duration
Patients who seek treatment earlier in their disease course tend to achieve better outcomes. However, meaningful improvements have been documented even in patients with longstanding conditions.
Overall Health
Patients in better overall health — non-smokers, healthy body weight, well-managed comorbidities — tend to have stronger stem cell responses and more durable improvements.
Treatment Protocol
Cell count, delivery method (IV, intrathecal, intra-articular), and use of adjunctive therapies (exosomes, PRP) all influence outcomes. Our protocols are personalized for each patient.
What "Success" Includes
Gerçekçi Beklentiler Belirlemek
We believe in honest, evidence-based communication. While 65–80% of patients experience meaningful improvement, this also means 35–35% may not respond as strongly. Factors like advanced disease stage, significant comorbidities, or unrealistic expectations can affect perceived outcomes.
During your free consultation, our medical team will review your specific case, discuss realistic expectations based on your condition stage and health profile, and provide an honest assessment of your candidacy.
Sıkça Sorulan Sorular
Aday Olup Olmadığınızı Öğrenin
Tıbbi ekibimiz, özel durumunuzu inceleyecek ve durumunuz ile hastalığınızın evresi hakkında gerçekçi beklentiler sunacaktır — tamamen ücretsiz, hiçbir yükümlülük olmadan.
İlgili Sayfalar
Tıbbi Sorumluluk Reddi: Belirtilen başarı oranları yayınlanmış klinik literatür ve meta-analizlerden alınmıştır. Bireysel sonuçlar, hastalığın şiddetine, hastanın sağlığına ve diğer faktörlere göre değişiklik gösterir. Bu içerik tıbbi tavsiye niteliği taşımaz. StemCell Longevita uluslararası bir hasta koordinasyon platformu olarak faaliyet göstermektedir.